PVM’s Dr. Michael Childress Appointed to Named Professorship in Comparative Oncology

Michael O. Childress, DVM, MS, DACVIM
Michael O. Childress, DVM, MS, DACVIM

A faculty member in Purdue Veterinary Medicine’s Department of Veterinary Clinical Sciences, Dr. Michael Childress, has been appointed as the Evan and Sue Ann Werling Professor of Comparative Oncology.  The appointment was ratified by the Purdue University Board of Trustees at its meeting Friday, June 7.

Dr. Childress has served on the College of Veterinary Medicine faculty since 2009. His research focuses on developing new therapies and identifying novel prognostic and predictive biomarkers for canine lymphomas.  Dr. Childress is board certified by the American College of Veterinary Internal Medicine (ACVIM) and is a member of the Phi Zeta Veterinary Honor Society, American Veterinary Medical Association, Veterinary Cancer Society, Purdue Institute for Cancer Research and Indiana Veterinary Medical Association.

A 2004 DVM graduate of the Virginia-Maryland Regional College of Veterinary Medicine, Dr. Childress completed a rotating internship at Kansas State University and an oncology internship at the University of Georgia before coming to Purdue University for a three-year residency in comparative oncology.  He completed the program and earned his MS degree in 2009.  His honors and awards include the Purdue Veterinary Medicine Excellence in Service Award, Purdue Veterinary Medicine Excellence in Research Award and the Veterinary Clinical Sciences Department Award for Excellence in Resident Mentoring.

Writer(s): Kevin Doerr | pvmnews@purdue.edu

Recent Stories

PVM White Coat Ceremony Celebrates Major Milestone for DVM Class of 2026

The Purdue Memorial Union ballrooms provided a classic setting for an annual event that has become a cherished tradition of the Purdue University College of Veterinary Medicine. Members of the DVM Class of 2026 gathered with family, friends and faculty and staff on the evening of April 12 for the annual White Coat Ceremony that signals the transition of the third year veterinary students from the classroom to the clinics.

Breast Cancer Drug Supinoxin Shows Potential for Small-cell Lung Cancer Treatment in New Tests

Purdue University scientists led by co-principal investigators in the Colleges of Agriculture and Veterinary Medicine have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung cancer (SCLC).

Tail-Wagging Success Characterizes PVM’s Participation in Purdue Day of Giving

As the day dawned Wednesday, April 30, evidence came pouring in that Boilermakers everywhere – whether alumni, friends and/or fans – were answering the call to make the 2025 Purdue Day of Giving our loudest and proudest “All hail!” yet. And Purdue Veterinary Medicine played a part in the success!

PVM’s Oncology Team Buoys Purdue Institute for Cancer Research 5K Fundraising Run

It is no surprise that the members of Purdue’s Werling Comparative Oncology Research Center (WCORC) in the College of Veterinary Medicine would not back down from a challenge, especially when it comes to supporting innovative cancer research. So, true to form, about two-dozen representatives of the center could be found out on the course Saturday, April 12, participating in the 17th annual 5K Challenge fundraising run to support the Purdue Institute for Cancer Research.

“Paws Up” – brought to you by the PVM Wellness Committee

This week we extend our appreciation to Lisa Hepworth, DVM, who is a senior lecturer and instructor of record for small animal junior surgery.